Readystate Asset Management LP lessened its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 95.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 13,236 shares of the company’s stock after selling 308,023 shares during the period. Readystate Asset Management LP’s holdings in BlackRock Health Sciences Term Trust were worth $190,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Baird Financial Group Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth about $189,000. Geneos Wealth Management Inc. purchased a new stake in BlackRock Health Sciences Term Trust in the first quarter worth $40,000. NewEdge Advisors LLC lifted its position in shares of BlackRock Health Sciences Term Trust by 134.3% during the second quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock worth $689,000 after purchasing an additional 27,686 shares during the last quarter. Jane Street Group LLC lifted its position in shares of BlackRock Health Sciences Term Trust by 157.1% during the second quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock worth $1,390,000 after purchasing an additional 59,559 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in BlackRock Health Sciences Term Trust by 14.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock worth $212,000 after buying an additional 1,787 shares during the period.
BlackRock Health Sciences Term Trust Trading Down 0.0%
Shares of BMEZ opened at $15.48 on Thursday. BlackRock Health Sciences Term Trust has a 1-year low of $13.67 and a 1-year high of $15.80. The company has a 50-day moving average of $14.91 and a 200 day moving average of $14.73.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
